Home Page 

Current Health News Archives

Essential Oils

Bella Mira Essential Oil Supplements

Organic Carrier Oils

Diffusers

Bella Mira Skin Care

Essential Oil Information and Use

Express Order Form

Essential Oil Singles

Essential Oil Blends

Essential Oil Kits

Essential Oil Supplies

Gluten Free

Gluten Free Living and Recipes

Important Information

Thyroid 101

Fibromyalgia 101

PAIN Relief and Information

Detoxification and Digestion Products

Pet Place

Save Your Computer Free Protection

Great Products

CD's DVD's and Books

3-D Screensavers

FREE Wellness Tests

Hormone Balance Test New Improved

Thyroid Function Test

Internal Toxicity Test

Gift Certificates

Link Exchange/Banners

Contact Us

Our Shopping Cart Is:

& FAQ

 

 

 

Deadly Stomach Bacteria Menaces Hospitals, Nursing Homes 11-12-08

The Bacteria, Clostridium difficile, responsible for severe intestinal distress, is much more common in the nation’s hospitals and nursing homes than previously thought, according to a recent survey of hundreds of hospitals across the United States.

The Association for Professionals in Infection Control and Epidemiology asked about 650 hospitals to choose any one day from this past summer (May through August) and review medical data for that day to identify C. difficile infection. The survey identified 1,443 patients infected with the bug, about 70% of whom were past the age of 60.

The survey suggests 13 of every 1,000 hospital patients is infected with the bacterium, or about 7,100 patients on any given day. This estimate is much higher, by as much as 6.5 times to 20 times higher, than previous estimates.

The C. difficile bacteria live in the colon and cause diarrhea. A severe infection can lead to colitis, which can be deadly, especially in elderly patients. Recent outbreaks proved fatal to as many as 100 patients in some hospitals.

The association revealed its survey findings at a medical conference recently held in Orlando, Florida. The research team urges hospitals and nursing homes to be more aware of this potentially deadly bacterium, which is becoming increasingly resistant to antibiotics. Recommended steps to control infection include more stringent cleaning methods, including the use of bleach as a disinfectant, and isolation of infected individuals.

Comments:

Here is The Lowdown on this bacteria:

The cause:

Commonly used heartburn drugs appear to be contributing to the rapid increase of community-acquired Clostridium difficile diarrheal infection.

Suppression of gastric acid with proton-pump inhibitors drugs like Prilosec (omeprazole) or Nexium (esomeprazole) is associated with a two- to threefold increase in the risk of community acquired Clostridium difficile, according to researchers here.

The finding supports the hypothesis that the mechanism of increased C. difficile risk is related to the degree of gastric acid suppression, Sandra Dial, M.D., M.Sc., of McGill University and colleagues reported in the Dec. 21 issue of the Journal of the American Medical Association.

Analysis of medical records from patients treated by general practitioners in England found that the incidence of C. difficile diagnosed by GPs jumped from less than 1 case per 100,000 population in 1994 to 22 cases per 100,000 in 2004.

That increase is mainly due to the increased use of gastric acid suppressors, wrote Dr. Dial and colleagues.

The adjusted relative risk for current proton pump inhibitor exposure was 2.9 and the adjusted relative risk for current H2 -receptor agonist exposure was 2.0. Current exposure to NSAIDs, but not aspirin, was also associated with a slight increase in risk of C. difficile. Proton pump inhibitors more effectively suppress gastric acid than H2 -receptor agonists.

Decreased gastric acidity, they wrote, is "a known risk factor for other infectious diarrheal illnesses such as travelers' diarrhea, salmonellosis, and cholera."

The concluded, "Acid-suppressive agents are among the most frequently prescribed medications in the United Kingdom and North America, and it is in this context that the contribution of these agents by potentially increasing the pool of susceptible hosts to the increasing rates of [C. difficile-associated disease] need to be considered and more completely characterized."

C. Difficile is usually considered a nosocomial infection, but in this analysis the researchers identified 1,233 cases among patients who had not been hospitalized in the year prior to diagnosis. Those 1,233 cases account for 74% of the 1627 cases of C. difficile identified in the General Practice Research Database.

The researchers compared cases with age-matched controls. Four hundred of the 1,233 cases were diagnosed by clinical symptoms and 833 were identified by positive toxin assay.

The mean age of patients with community-acquired C. difficile was 71 and most of the cases were women. Other factors associated with C. difficile were history of renal failure, inflammatory bowel disease, malignancy, and methicillin-resistant Staphylococcus aureus-positive.

The symtoms:

Clostridium difficile, (also known as CDF/cdf', or 'C. diff') is a species of bacteria of the genus Clostridium which are Gram-positive bacilli, anaerobic, spore-forming rods (bacillus).C. difficile is the most significant cause of pseudo membranous colitis. It is a severe infection of the colon, often happening after normal gut flora is eradicated by use of antibiotics. The C. difficile bacteria, which naturally reside in the body, become overgrown. A C. difficile overgrowth is harmful because the bacterium releases toxins that cause:

* Bloating and constipation
* Diarrhea with abdominal pain
* Severe diarrhea with mucus and blood present in feces and characterized by body aches and severe abdominal pain caused from ulcerated intestines.

The latent symptoms often mimic some flu-like symptoms. Treatment is performed by stopping current treatment and commencing specific anticlostridial antibiotics, e.g. metronidazole or Vancomycin.

Bacteriology
Individual drumstick shaped C. diff bacilli seen through electronmicroscopy

Clostridia are motile bacteria that are ubiquitous in nature and are especially prevalent in soil. Under the microscope after Gram staining, they appear as long drumsticks with a bulge located at their terminal ends. Clostridium difficile cells are Gram positive and show optimum growth on blood agar at human body temperatures in the absence of oxygen. When stressed, the bacteria produce spores which tolerate extreme conditions that the active bacteria cannot tolerate.

First described by Hall and O'Toole in 1935, "the difficult clostridium" was resistant to early attempts at isolation and grew very slowly in culture.

C. difficile is a commensal bacterium of the human intestine in a minority of the population. Patients who have been staying long-term in a hospital or a nursing home have a higher likelihood of being colonized by this bacterium. In small numbers it does not result in disease of any significance. Antibiotics, especially those with a broad spectrum of activity, cause disruption of normal intestinal flora, leading to an overgrowth of C. difficile, which flourishes under these conditions. This leads to pseudo membranous colitis.

C. difficile is resistant to most antibiotics. It is transmitted from person to person by the fecal-oral route. Because the organism forms heat-resistant spores, it can remain in the hospital or nursing home environment for long periods of time. It can be cultured from almost any surface in the hospital. Once spores are ingested, they pass through the stomach unscathed because of their acid-resistance. They change to their active form in the colon and multiply.

It has been observed that several disinfectants commonly used in hospitals may fail to kill the bacteria, and may actually promote spore formation. However, disinfectants containing bleach are effective in killing the organisms. However a safer silver based disinfectant is available. Hospitals use bleach because it is cheap.

Toxins

Pathogenic C. difficile strains produce various toxins. The most well-characterized are enterotoxin (toxin A) and cytotoxin (toxin B).These two toxins are both responsible for the diarrhea and inflammation seen in infected patients, although their relative contributions have been debated by researchers. Another toxin, binary toxin, has also been described, but its role in disease is not yet fully understood.[5]

Role in disease

With the introduction of broad-spectrum antibiotics in the latter half of the twentieth century, antibiotic-associated diarrhea became more common. Pseudo membranous colitis was first described as a complication of C. difficile infection in 1978,[6] when a toxin was isolated from patients suffering from pseudo membranous colitis and Koch's postulates were met.

Clostridium difficile infection (CDI) can range in severity from asymptomatic to severe and life threatening, and many deaths have been reported, especially amongst the aged. People are most often infected in hospitals, nursing homes, or institutions, although C. difficile infection in the community, outpatient setting is increasing. Clostridium difficile associated diarrhea (aka CDAD) has been linked to use of broad-spectrum antibiotics such as cephalosporins and clindamycin, though the use of quinolones is now probably the most likely culprit; quinolones are frequently used in hospital settings. Frequency and severity of C. difficile colitis remains high and seems to be associated with increased death rates. Immuno-compromised status and delayed diagnosis appear to result in elevated risk of death. Early intervention and aggressive management are key factors to recovery.

The rate of Clostridium difficile acquisition is estimated to be 13% in patients with hospital stays of up to 2 weeks and 50% in those with hospital stays longer than 4 weeks.

Increasing rates of community-acquired Clostridium difficile-associated infection/disease (CDAD) have also been linked to the use of medication to suppress gastric acid production: H2-receptor antagonists increased the risk twofold, and proton pump inhibitors threefold, mainly in the elderly. It is presumed that increased gastric pH, (alkalinity), leads to decreased destruction of spores.

Diagnosis

In order to prevent complications, clinicians often begin treatment based on clinical presentation before results have come back. Knowledge of the local epidemiology of intestinal flora of a particular institution can guide therapy.

Prevention/Treatment:

Many persons will also be asymptomatic and colonized with Clostridium difficile. Treatment in asymptomatic patients is controversial, also leading into the debate of clinical surveillance and how it intersects with public health policy.

It is possible that mild cases do not need treatment.

Patients should be treated as soon as possible when the diagnosis of Clostridium difficile colitis (CDC) is made to avoid frank sepsis or bowel perforation.

Besides avoiding Clostridium difficile by not taking antacids, proper hand cleaning, proper bathroom cleaning and habits, and staying out of hospitals you can help your intestinal tract become inhospitable to it.

Having a intestinal tract full of friendly bacteria keeps Clostridium difficile from taking hold there. Eat a healthy diet low in simple sugars and artificial chemicals as well as consuming cultured foods and Bella Mira Perfect Flora HSO's. Studies have shown that Clostridium difficile wont grown in an alkaline environment. Well neither will most disease. Eat in moderation: meat, cheese and dairy, eat 50 to 75% of your daily food intake in fruits and vegetables and juices, consume no grains, no simple sugars or artificial sweeteners and drink pure water. If these steps aren't enough than add Bella Mira PH Rescue to your daily regimen.

Should you become ill with Clostridium difficile here are some things to try. However should you get dehydrated, run a high fever, have immense pain, or are not improving; seek medical attention immediately!

Bentonite, Zeolite or Activated Charcoal: May be beneficial in easing pain and bloating as well as removing toxins.

Silver Biotics: Ionic Colloidal Silver is one of the strongest Antibiotics known to man and can be combined with any other antibacterial regimen. Ionic Colloidal Silver can be taken daily and will not harm friendly bacteria or cause antibiotic resistance. Silver Biotics action is physical not microbial and microbes cannot become immune!

Antibacterial Essential Oils: Click the link and they will all be listed:

Food Grade Peroxide: 1 drop of 35% food grade peroxide in 16 oz of water 1-3 times a day.

Ozonated water: This may be drunk or used as an enema if you have it available.

Bella Mira Perfect Flora HSO's: To kill the bad bacteria and repopulate the good bacteria.

Search Clostridium difficile:

Search Bacterial Infection:

Search Antacids: